Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Quinn

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Pathogens (Basel, Switzerland)|April 10, 2019
ApiAP2 Transcription Factors in Apicomplexan ParasitesMyriam D Jeninga, Jennifer E Quinn, Michaela Petter
Lancet (London, England)|October 18, 2002
BRCA1: mechanisms of inactivation and implications for management of patientsRichard D Kennedy, Jennifer E Quinn, Patrick G Johnston, et al.
Gynecologic Oncology|January 27, 2009
BRCA1 and implications for response to chemotherapy in ovarian cancerJennifer E Quinn, Judith E Carser, Colin R James, et al.
The Oncologist|February 14, 2007
BRCA1, a potential predictive biomarker in the treatment of breast cancerColin R James, Jennifer E Quinn, Paul B Mullan, et al.
Journal of the National Cancer Institute|November 18, 2004
The role of BRCA1 in the cellular response to chemotherapyRichard D Kennedy, Jennifer E Quinn, Paul B Mullan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous CarcinomaTara Byrne, Laura Nelson, James P Beirne, et al.
Frontiers in Cell and Developmental Biology|May 2, 2022
The Putative Bromodomain Protein PfBDP7 of the Human Malaria Parasite <i>Plasmodium Falciparum</i> Cooperates With PfBDP1 in the Silencing of Variant Surface Antigen ExpressionJennifer E Quinn, Myriam D Jeninga, Katharina Limm, et al.
Cancer Research|October 16, 2003
BRCA1 functions as a differential modulator of chemotherapy-induced apoptosisJennifer E Quinn, Richard D Kennedy, Paul B Mullan, et al.
Oncogene|June 9, 2005
The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-gamma-mediated apoptosisPaul B Mullan, Alison M Hosey, Niamh E Buckley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 11, 2012
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinomaJames P Beirne, Jennifer E Quinn, Perry Maxwell, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Pathogens (Basel, Switzerland)|April 10, 2019
ApiAP2 Transcription Factors in Apicomplexan ParasitesMyriam D Jeninga, Jennifer E Quinn, Michaela Petter
Lancet (London, England)|October 18, 2002
BRCA1: mechanisms of inactivation and implications for management of patientsRichard D Kennedy, Jennifer E Quinn, Patrick G Johnston, et al.
Gynecologic Oncology|January 27, 2009
BRCA1 and implications for response to chemotherapy in ovarian cancerJennifer E Quinn, Judith E Carser, Colin R James, et al.
The Oncologist|February 14, 2007
BRCA1, a potential predictive biomarker in the treatment of breast cancerColin R James, Jennifer E Quinn, Paul B Mullan, et al.
Journal of the National Cancer Institute|November 18, 2004
The role of BRCA1 in the cellular response to chemotherapyRichard D Kennedy, Jennifer E Quinn, Paul B Mullan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous CarcinomaTara Byrne, Laura Nelson, James P Beirne, et al.
Frontiers in Cell and Developmental Biology|May 2, 2022
The Putative Bromodomain Protein PfBDP7 of the Human Malaria Parasite <i>Plasmodium Falciparum</i> Cooperates With PfBDP1 in the Silencing of Variant Surface Antigen ExpressionJennifer E Quinn, Myriam D Jeninga, Katharina Limm, et al.
Cancer Research|October 16, 2003
BRCA1 functions as a differential modulator of chemotherapy-induced apoptosisJennifer E Quinn, Richard D Kennedy, Paul B Mullan, et al.
Oncogene|June 9, 2005
The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-gamma-mediated apoptosisPaul B Mullan, Alison M Hosey, Niamh E Buckley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 11, 2012
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinomaJames P Beirne, Jennifer E Quinn, Perry Maxwell, et al.
Pageof 3